SHH and metabolic dysfunction-associated steatotic liver disease: Next, we performed a transcriptome analysis and found that after Shh treatment, pathways associated with ribosome, oxidative phosphorylation, neurodegenerative diseases, thermogenesis, NAFLD, and proteasome were significantly enriched (Supplementary Fig. 8a, b).